Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019
© Commonwealth of Australia CC BY-NC-ND..
The Australian Paediatric Surveillance Unit (APSU) has been prospectively collecting national data on rare childhood conditions since 1993, with monthly reporting of cases by paediatricians. In this report we describe annual results from studies for ten communicable diseases and complications of communicable diseases that were conducted using APSU surveillance in 2019 and place these in an historic context. Results are reported on acute flaccid paralysis, congenital cytomegalovirus infection, neonatal herpes simplex virus infection, perinatal exposure to HIV, paediatric HIV infection, severe complications of seasonal influenza, juvenile onset recurrent respiratory papillomatosis (JoRRP), congenital rubella syndrome, congenital varicella syndrome and neonatal varicella infection. APSU provides rich clinical data to complement data collected from other surveillance systems and to improve understanding and response to rare childhood infections.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Communicable diseases intelligence (2018) - 44(2020) vom: 17. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Teutsch, Suzy M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Australia |
|---|
| Anmerkungen: |
Date Completed 14.06.2021 Date Revised 14.06.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.33321/cdi.2020.44.60 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314033327 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314033327 | ||
| 003 | DE-627 | ||
| 005 | 20231225151846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.33321/cdi.2020.44.60 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM314033327 | ||
| 035 | |a (NLM)32829700 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Teutsch, Suzy M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2021 | ||
| 500 | |a Date Revised 14.06.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Commonwealth of Australia CC BY-NC-ND. | ||
| 520 | |a The Australian Paediatric Surveillance Unit (APSU) has been prospectively collecting national data on rare childhood conditions since 1993, with monthly reporting of cases by paediatricians. In this report we describe annual results from studies for ten communicable diseases and complications of communicable diseases that were conducted using APSU surveillance in 2019 and place these in an historic context. Results are reported on acute flaccid paralysis, congenital cytomegalovirus infection, neonatal herpes simplex virus infection, perinatal exposure to HIV, paediatric HIV infection, severe complications of seasonal influenza, juvenile onset recurrent respiratory papillomatosis (JoRRP), congenital rubella syndrome, congenital varicella syndrome and neonatal varicella infection. APSU provides rich clinical data to complement data collected from other surveillance systems and to improve understanding and response to rare childhood infections | ||
| 650 | 4 | |a Historical Article | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Australia | |
| 650 | 4 | |a child | |
| 650 | 4 | |a communicable diseases | |
| 650 | 4 | |a public health surveillance | |
| 650 | 4 | |a rare diseases | |
| 700 | 1 | |a Nunez, Carlos A |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a McGregor, Skye |e verfasserin |4 aut | |
| 700 | 1 | |a King, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Brotherton, Julia Ml |e verfasserin |4 aut | |
| 700 | 1 | |a Novakovic, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Booy, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Cheryl A |e verfasserin |4 aut | |
| 700 | 1 | |a Rawlinson, William |e verfasserin |4 aut | |
| 700 | 1 | |a Thorley, Bruce R |e verfasserin |4 aut | |
| 700 | 1 | |a Elliott, Elizabeth J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Communicable diseases intelligence (2018) |d 2018 |g 44(2020) vom: 17. Aug. |w (DE-627)NLM292546858 |x 2209-6051 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2020 |g day:17 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.33321/cdi.2020.44.60 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2020 |b 17 |c 08 | ||